Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Corticosteroid Eyedrops Market Size And Revenue Outlook Through 2030
The corticosteroid eyedrops market has experienced robust expansion recently. This market is projected to expand from $10 billion in 2025 to $10.67 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this historical growth include the constrained supply of corticosteroid formulations, dependence on hospital pharmacies, a rise in ophthalmic surgeries, increased understanding of ocular inflammation treatment, and the established use of prednisolone and dexamethasone.
The corticosteroid eyedrops market is projected to experience robust expansion over the coming years, set to reach $13.69 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.4%. This growth during the forecast period is expected to stem from the advancement of combination therapy eyedrops, an increase in pediatric ophthalmology treatments, the expansion of online pharmacy distribution channels, greater adoption of patient-centric drug delivery devices, and new regulatory approvals for innovative corticosteroid formulations. Key trends anticipated in this period encompass the increasing incidence of eye conditions necessitating anti-inflammatory treatment, a rising preference for combination therapy eyedrops, wider integration of pediatric-friendly formulations, an expansion of both online and traditional retail pharmacy outlets, and a strong emphasis on enhancing drug stability and patient adherence.
Get A Free Sample Report With In-Depth Market Insights:
Corticosteroid Eyedrops Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The expanding occurrence of eye conditions is anticipated to fuel the expansion of the corticosteroid eyedrops market in the future. Eye diseases are defined as ailments impacting the eyes’ health and function, which can potentially result in vision impairments or even blindness if not adequately addressed. The increase in eye disease prevalence stems from greater screen time, which causes digital eye strain and contributes to issues like dry eye and blurred vision. Corticosteroid eyedrops are frequently employed to manage eye conditions by diminishing inflammation and alleviating symptoms such as redness, swelling, and discomfort. For instance, in May 2024, a report from the Joint Strategic Needs Assessment, a UK-based community health center, indicated that approximately 2 million individuals in the UK currently experience some level of sight loss, a figure expected to reach 2.7 million by 2030. Consequently, the growing prevalence of eye diseases is propelling the corticosteroid eyedrops market’s growth.
Corticosteroid Eyedrops Market Segment Performance And Emerging Opportunities
The corticosteroid eyedrops market covered in this report is segmented –
1) By Product Type: Topical Corticosteroid Eyedrops, Systemic Corticosteroid Eyedrops, Combination Therapy Eyedrops
2) By Delivery Device: Dropper Bottles, Spray Formulations, Ointments And Gels, Punctal Plugs
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
4) By Application: Adult, Children
5) By End User: Hospitals, Specialty Clinics, Community Pharmacies, Online Pharmacies
Subsegments:
1) By Topical Corticosteroid Eyedrops: Prednisolone Acetate Eyedrops, Dexamethasone Eyedrops, Fluorometholone Eyedrops, Loteprednol Etabonate Eyedrops, Rimexolone Eyedrops
2) By Systemic Corticosteroid Eyedrops: Hydrocortisone-Based Eyedrops, Methylprednisolone-Based Eyedrops, Triamcinolone-Based Eyedrops, Betamethasone-Based Eyedrops
3) By Combination Therapy Eyedrops: Corticosteroid + Antibiotic Combination Eyedrops, Corticosteroid + Non-Steroidal Anti-Inflammatory Drug (NSAID) Eyedrops, Corticosteroid + Antihistamine Eyedrops, Corticosteroid + Antiglaucoma Agent Eyedrops
Corticosteroid Eyedrops Market Innovation Trends Shaping Future Development
Leading companies in the corticosteroid eyedrops market are concentrating on securing regulatory approvals to broaden their product portfolios and enhance market access. Regulatory approvals denote the official authorization granted by health authorities, ensuring that corticosteroid eyedrops comply with required safety, efficacy, and quality standards before being commercialized and prescribed to patients. For instance, in March 2024, Formosa Pharmaceuticals Inc., a Taiwan-based pharmaceutical company, and AimMax Therapeutics, a US-based pharmaceutical company, obtained FDA approval for clobetasol propionate ophthalmic suspension 0.05% (APP13007) designed for the management of postoperative inflammation and pain following ocular surgery. Developed using Formosa’s APNT nanoparticle technology, this corticosteroid formulation facilitates effective drug delivery through a simple twice-daily dosing for 14 days without tapering. Clinical trials demonstrated its strong anti-inflammatory effects, positioning it as a promising addition to corticosteroid treatment options for alleviating inflammation and pain after eye surgery. As the first ophthalmic corticosteroid containing clobetasol and the first new steroid approved in this category in over 15 years, it signifies a major advancement in ocular corticosteroid therapy.
Corticosteroid Eyedrops Market Key Players: Which Companies Lead Industry Competition?
Major companies operating in the corticosteroid eyedrops market are Pfizer Inc., AbbVie Inc., Novartis AG, Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Cipla Ltd., Santen Pharmaceutical Co. Ltd., Lupin Limited, Zydus Lifesciences Limited, Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Sunways Pvt. Ltd., FDC Limited, Eurocrit Labs International Pvt. Ltd., Entod Pharmaceuticals Pvt. Ltd., Akorn Pharmaceuticals Inc., Kala Pharmaceuticals Inc.
View The Full Corticosteroid Eyedrops Market Report:
Corticosteroid Eyedrops Market Geographic Analysis: Where Is Demand Accelerating Fastest?
North America was the largest region in the corticosteroid eyedrops market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the corticosteroid eyedrops market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model